ARCHIVES

5-FU/Levamisole A community Success Story; Trials With Untreated Control Revised Or Dropped

This article is from The Cancer Letter archive.

Vol. 15 No. 39 | October 13, 1989

Download PDF Visit The Full Archive

Related Articles

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

In Brief: Whittaker Corp, Trying To Hire NCI Director; Environmental Carcinogenesis On NCAB Agenda

February 13, 1976

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Center And Cooperative Group Clinical Trials Approved By NCI

May 27, 2005

NCI RFA: Basic Biobehavioral Research

August 6, 1999

NCI Drug Development Program Produced 7 Drugs In 10 Years, Chabner Tells Group

February 3, 1995